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Abstract
A decade ago, the Partnership for Maternal, Newborn and Child Health (PMNCH) was established
to combat the growing fragmentation of global health action into uncoordinated, issue-specific ef-
forts. Inspired by dominant global public-private partnerships for health, the PMNCH brought
together previously competing advocacy coalitions for safe motherhood and child survival and at-
tracted support from major donors, foundations and professional bodies. Today, its founders high-
light its achievements in generating priority for ‘MNCH’, encouraging integrated health systems
thinking and demonstrating the value of collaboration in global health endeavours. Against this
dominant discourse on the success of the PMNCH, this article shows that rhetoric in support of
partnership and integration often masks continued structural drivers and political dynamics that
bias the global health field towards vertical goals. Drawing on ethnographic research, this article
examines the Safe Motherhood Initiative’s evolution into the PMNCH as a response to the competi-
tive forces shaping the current global health field. Despite many successes, the PMNCH has
struggled to resolve historically entrenched programmatic and ideological divisions between the
maternal and child health advocacy coalitions. For the Safe Motherhood Initiative, the cost of oper-
ating within an extremely competitive policy arena has involved a partial renouncement of ambi-
tions to broader social transformations in favour of narrower, but feasible and ‘sellable’ interven-
tions. A widespread perception that maternal health remains subordinated to child health even
within the Partnership has elicited self-protective responses from the safe motherhood contingent.
Ironically, however, such responses may accentuate the kind of fragmentation to global health gov-
ernance, financing and policy solutions that the Partnership was intended to challenge. The article
contributes to the emerging critical ethnographic literature on global health initiatives by highlight-
ing how integration may only be possible with a more radical conceptualization of global health
governance.
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Introduction
In 1987, the Safe Motherhood Initiative (SMI) was launched to bring
attention to the ‘neglected tragedy’ of maternal mortality, amidst frus-
tration that the M in MCH—maternal and child health—had been
marginalized by the prevailing focus on child survival in international
health efforts (Rosenfield and Maine 1985; Starrs 1987). Ironically, in
2005, the Partnership for Maternal, Newborn and Child Health
(PMNCH) was formed at the ‘Lives in the Balance’ meeting in New
Delhi to bring maternal and child initiatives back together. Its mission
was ‘to support the global health community to work successfully to-
wards achieving MDG 4 and 5’ on child survival and maternal health
(PMNCH 2009a, p. 12). In the decade since, the PMNCH has grown
from 80 to over 500 members, attracted donor funding from govern-
ments, multilateral organizations and private foundations, and
spawned a number of high-profile global initiatives (PMNCH 2014).
The rise of the PMNCH is but one example of a much larger
trend driven by two potentially contradictory forces. First is the
long-standing recognition that global health initiatives have often
been unproductively fragmented according to disease-based expert-
ise and that to remedy this problem, greater attention to ‘integra-
tion’ at the level of policy, governance, financing strategies, research
and actual programme implementation is needed (Travis et al. 2004;
McCoy 2009; Atun et al. 2010). Much of this debate about integra-
tion concerns how to reconcile the tension between narrowly tar-
geted interventions and those providing broader system-wide
support (Buffardi 2014). The second force is the rapid proliferation
during the past 15 years of global public-private partnerships (PPPs)
that invest in specific diseases and interventions through joint deci-
sion-making among multiple partners from the public and private
sectors, including multilateral agencies, donor bodies, philanthropic
foundations and civil society (Reich 2002; Buse and Harmer 2007;
Harmer 2011). While most focus on single diseases, some PPPs—
like the PMNCH—have explicitly organized their work to reduce
duplication of efforts by creating initiatives that bring together dif-
ferent groups of disease-specialists to better coordinate efforts under
the same programmatic umbrella. This networking of resources and
expertise—what political scientists call the production of ‘trans-
national advocacy coalitions’ (Sabatier and Jenkins-Smith 1993;
Stone 2002)—has been highly successful both politically and finan-
cially (Shiffman et al. 2015). The two largest partnerships, the
Global Fund and GAVI (the Vaccine Alliance), almost single-hand-
edly brought about the 4-fold increase in development assistance to
the health sector between 1999 and 2005 (Ravishankar et al. 2009).
Despite such successes at a global level, critics have been quick
to demonstrate that the business-oriented ethos that PPPs typically
endorse has in fact amplified competition between initiatives,
increased bureaucratization and further fragmented global health
governance on the ground, thereby undermining coordinated and
sustainable health action (Be´hague et al. 2009; McCoy 2009; Taylor
and Harper 2014). This fragmentation, many argue, results from the
increased agenda-setting power of private foundations, notably the
Bill and Melinda Gates Foundation, which has undermined the abil-
ity of publicly mandated institutions like the World Health
Organization and recipient governments to promote integrated
health policies, threatening democratic global health governance
(Cueto 2004; Brown et al. 2006; McCoy and McGoey 2011; Birn
2014). Moreover, ethnographic studies have demonstrated that pri-
vate foundations’ success in shaping health policy in line with their
convictions has often been achieved by limiting their focus to ‘safe
issues’ and marginalizing other perspectives, as in the case of mal-
aria (Eckl 2014), or by appropriating broader policy agendas, as in
the case of GAVI’s health system strengthening investment (Storeng
2014). An emerging body of social scientific research points to the
detrimental effects of friction among ‘partners’ at global, national
and sub-national levels, for instance the way in which civil society
organizations’ weak position within PPPs limits their impact on na-
tional policy-making, and can result in co-option of progressive dis-
courses by stronger partners and stifling of critical voices (Doyle and
Patel 2008; Harmer et al. 2012; Kapilashrami and McPake 2012;
Kapilashrami and O’Brien 2012; Grebe 2015). Today, key donors
and governments embrace the rhetoric of ‘integration’ at multiple
levels, but they continue to favour issue-specific partnerships and
judge success in terms of disease-specific performance (Birn 2009),
without acknowledging the potential contradiction at play.
On the spectrum of different kinds of PPPs, the PMNCH has in
many ways been at the forefront of explicitly addressing the contra-
dictions that privatization of global health poses for coordinated
global health governance, for its raison d’etre was ostensibly to re-
solve tensions that had been dividing the maternal and child health
communities since the 1980s. Flavia Bustreo, the Partnership’s dir-
ector from 2006 to 2010, has argued that ‘the potential of the
PMNCH to unify the previously fragmented maternal, newborn and
child health (MNCH) communities created a positive atmosphere
and sparked productive collaborations across sectors and constitu-
encies’ (Bustreo et al. 2012, p. S7). The increased visibility of the
‘MNCH’ agenda, she argues, helped promote a ‘continuum of care’
approach in maternal, newborn and child health care initiatives,
thereby fostering greater appreciation for integrated health systems
thinking (Bustreo et al. 2012, p. S7).
Against this dominant narrative on the PMNCH’s success, this
article examines ethnographically the practical tensions and contest-
ations that have emerged as key PMNCH actors attempt to put the
ideals of ‘partnership’ and ‘integration’ into practice. While
recognizing that integration of services on the ground is extremely
complex (Atun et al. 2010; Church et al. 2015), we seek to under-
stand how the partnership ideal works out in terms of integration of
institutional structures and policy approaches at the global level.
Did the PMNCH in the end help integrate divisive groups of experts
Key Messages
• The Partnership for Maternal, Newborn and Child Health (PMNCH) was formed to combat fragmentation in global
health.
• Despite many successes, the PMNCH’s attempt to foster partnerships and advance an integrated global policy approach
generated competitive tensions and elicited self-protective responses.
• Rhetoric in support of integration often masks continued structural drivers and political dynamics that bias the global
health field towards vertical goals.
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in the global arena? Did it advance an integrated policy approach?
Through an ethnographic case study of the SMI’s growth and evolu-
tion into the PMNCH, we aim to show that the PMNCH has
struggled to resolve historically entrenched differences in public
health ideology and approaches between the maternal and child
health communities. These relate to the relative emphasis on com-
prehensive versus selective approaches to health and the role of
long-term health system development versus the pursuit of magic
bullets. Despite recent claims that the PMNCH is ‘a testament to
growing emphasis on collaboration as the most effective way for-
ward to improving the lives of women, newborn and children’
(Bustreo et al. 2012, p. 8), we explore how the politics of institu-
tional control and distinct advocacy coalitions’ tendency towards
competition for funding and attention have posed a challenge to ef-
fective collaboration—or partnership—between expert groups. We
end by reflecting on whether the current partnership model that
dominates global health governance is equipped to meet the chal-
lenges of achieving institutional and programmatic integration.
Methods
This article draws on a broader historical ethnography of the SMI
(Be´hague and Storeng 2008; Storeng 2010), carried out between
2004 and 2009, when the SMI was evolving into the PMNCH. Our
analysis draws on participant observation within research commun-
ities and at policy events and in-depth confidential interviews with
72 informants from multilateral agencies, academic institutions,
professional bodies and international non-governmental organiza-
tions, primarily at the global level (see Table 1). Most considered
themselves maternal health experts, but some had expertise in child
health, health systems and policy. Many of our informants were dir-
ectly involved in the PMNCH as secretariat staff, donors or commit-
tee representatives. They provided an insider perspective, while data
from participant observation and interviews with other global
health experts provided an outsider perspective. The interviews were
open-ended, and covered professional trajectories, perspectives and
experiences of the historic tensions between the maternal and child
health fields, the SMI’s history and identity, the formation and suc-
cess of the PMNCH, responses to the evidence-based policy-making
movement and the impact of competition on research and policy.
During our fieldwork, we also worked as researchers within an
interdisciplinary Research Programme Consortium on maternal and
newborn health funded by the UK Department for International
Development (DFID), which gave us access to debates about the
PMNCH as they played out within expert communities and at
focusing events, such as the first PMNCH high-level meeting in
India in 2005. To examine the SMI’s development into the
PMNCH, we also draw on historical and contemporary policy
documents and scientific literature and oral histories collected
during in-depth interviews. For further details of the methods please
see Be´hague and Storeng 2008 and Storeng and Be´hague 2014.
Results
The SMI’s contested beginnings
The emergence of the PMNCH can best be understood within the
contested beginnings of the SMI, and particularly the ideological
and programmatic differences that polarized the maternal and child
health communities during the 1980s. Healthcare for mothers and
children—so-called MCH services—had been at the heart of the
1978 Alma-Ata Declaration on Primary Health Care (PHC) in 1978
(WHO and UNICEF 1978). However, according to informants who
had worked within international health at the time, by the early
1980s international public health specialists started voicing concern
that maternal health was being neglected in favour of child health.
This neglect was part of a broader backlash against the principles of
the Alma-Ata declaration initiated by governments, agencies and in-
dividuals who proposed ‘selective’ PHC as a more pragmatic, finan-
cially palatable, and politically unthreatening alternative to
comprehensive PHC (Cueto 2004). Critics have argued that selective
PHC, being focused on a small number of cost-effective interven-
tions only, reduced Alma-Ata’s idealism to ‘a practical set of tech-
nical interventions whose implementation and effects could be
readily measured’ (Brown et al. 2006, p. 67) and abandoned its
focus on equity and health systems development (Magnussen et al.
2004), aspects that maternal health specialists were particularly pas-
sionate about. UNICEF’s child survival strategy became the epitome
of selective PHC, focused on improving survival of children through
a set of targeted interventions (growth monitoring, oral rehydration
therapy, breastfeeding and immunization), summarized as GOBI
(Cash et al. 1987). Criticized as a ‘Band-Aid’, GOBI nevertheless be-
came popular with donors, not least because it enabled them to tie
their financial inputs to specific interventions and outcomes (Cueto
2004).
According to a senior Belgian maternal health specialist we inter-
viewed, enthusiasm for GOBI’s low-cost community-based solutions
engendered an ‘anti-high tech predilection’ among donors, under-
mining support for professionalized facility-based obstetric care,
which experts saw as essential to prevent maternal deaths. It was
this view that led the authors of a seminal Lancet article to ask,
‘Where is the M in MCH?’ (Rosenfield and Maine 1985),
galvanizing interest in an international SMI as a counterweight to
UNICEF’s Child Survival Revolution. This initiative, launched in
1987, was governed by an Inter-Agency Group with representatives
from UN technical agencies (WHO, UNICEF, UNFPA), the World
Bank and an NGO-based secretariat (Family Care International)
and gradually expanded to incorporate other NGOs and academics
(AbouZahr 2003).
The SMI was successful in bringing international attention to
maternal mortality in low- and middle-income countries; within a
few years, safe motherhood conferences had been held in every
world region and many countries had set up dedicated maternal
health programmes. However, the creation of the SMI also ce-
mented competition between the maternal and child fields.
Throughout the late 1980s and 1990s, the ‘MCH’ concept was grad-
ually dismantled in favour of separate public health responses tar-
geted at women and children, and competition between maternal
and child health for scarce resources intensified (Lawn et al. 2006).
Meanwhile, debates about whether resources should be invested in
the provision of community-based approaches or facility-based
Table 1. Distribution of informants according to role at the time of
the interview
Role Number
United Nations agency officials 12
Bilateral agency officials 11
International academic researchers 23
NGOs or foundation representatives 17
National-level policy makers,
programme managers and researchers
9
Total 72
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services, and on how to balance short-term urgent demands for sav-
ing lives with long-term needs for public health system strengthen-
ing, became increasingly polarized (see McCoy et al. 2010).
In contrast to the selective GOBI approach, the SMI proposed a
comprehensive policy agenda combining action on obstetric care,
health system development and the social determinants of poor ma-
ternal health, including women’s low status (Starrs 1987).
According to one of the initiative’s founders, the name ‘safe mother-
hood’ was strategically chosen to encompass all these issues:
One of the things that was so useful about the term ‘safe mother-
hood’ from the very beginning was that it’s something no one
could say they were against. The most hardnosed unsentimental
decision-maker or economist has a mother, sister, wife or daugh-
ter. Nobody can say they are opposed to reducing maternal mor-
tality . . . and if you take the broad approach to maternal health
you bring in issues not just of training of mid-wives and supply-
ing health facilities but also the issues of education for girls, for
women’s status and women’s rights in society . . . but you can do
so in a way which is not so threatening.
Despite the SMI’s comprehensive vision, once faced with the eco-
nomic crisis of the 1980s and health systems weakened by structural
adjustment, many low-income country governments and donors
narrowed their maternal health programmes to a limited set of com-
munity-based interventions: training of traditional birth attendants
and antenatal screening for high-risk pregnancies. Ironically, these
were the very interventions SMI founders had rejected as inadequate
for tackling maternal mortality.
Maintaining momentum for the SMI’s broad agenda became in-
creasingly difficult in the 1990s, especially when the SMI became
implicated in the controversy that erupted at the UN International
Conference on Population and Development (ICPD) in Cairo 1994
over reproductive health and rights, notably over the issue of abor-
tion. Because the SMI had identified unsafe abortion as a main cause
of maternal mortality, many conservative governments came to see
safe motherhood as a ‘Trojan horse’ for the introduction of abortion
rights, and withdrew their support (AbouZahr 2001). This
prompted the SMI to distance itself from abortion and women’s
right in favour of a more instrumental focus on preventing maternal
deaths through skilled birth attendance (delivery by a professional
mid-wife or doctor) and emergency obstetric care (EmOC) (Storeng
& Be´hague 2013).
By the end of the decade, what we term a narrative of failure had
established itself within the field, with influential editorials reflect-
ing on persistently high levels of maternal mortality and the SMI’s
failure to achieve its programmatic aims and sustain political mo-
mentum (e.g. Maine and Rosenfield 1999; AbouZahr 2001). In
interviews, some of those who had been active within the SMI in its
early years blamed institutional weakness and a lack of leadership
for lagging progress. ‘We never had a Jim Grant’, noted one such in-
formant, referring to UNICEF’s charismatic leader in the 1980s,
while another sardonically asked, ‘you ask people to cite two or
three people who are shouting for maternal health in the media, in
the public and they will not be able to say one. They won’t say any-
thing, but for child health they will immediately say UNICEF’.
From the 1990s onwards, the SMI also struggled to respond to
donors’ and policy-makers’ increasing demand for quantitative evi-
dence of the cost-effectiveness of their investments, as we have dis-
cussed in more detail elsewhere (Be´hague and Storeng 2008, Storeng
and Be´hague 2014). The idea of that SMI was stuck in a ‘measure-
ment trap’ (Graham and Campbell 1992)—a negative feedback loop
where measurement challenges led to lack of evidence and neglect of
maternal health in research and programmes—became a dominant
way of explaining the SMI’s lack of power, success and funding.
The challenges posed by growing demand for evidence were rein-
forced by the rise of the ‘new philanthropy’, exemplified by the
Gates Foundation, which instated management-style performance
accountability measures to guide assessments and programming.
This encouraged a bias in favour of narrow technical interventions
whose value was easier to demonstrate, in place of the preceding
era’s broader approach to health and social well-being (Birn 2009).
The Gates Foundation’s entry also precipitated the establishment
of major global PPPs for health with which the SMI struggled to
compete. The rapid rise of the Global Fund to Fight AIDS,
Tuberculosis and Malaria, for instance raised concerns that ‘AIDS
exceptionalism’ was fuelling neglect of maternal health, a fear at
least partially substantiated by independent analyses (Crossette
2005; Shiffman 2007). While both maternal health and child sur-
vival were included among the MDGs in 2001, prominent maternal
health experts recalled how the Gates Foundation’s support for child
health through the establishment of the vaccine alliance GAVI in
2000 and Saving Newborn Lives (later the Healthy Newborn
Partnership) in 2004 marginalized maternal health.
Around the same time, international debate about the need to in-
crease ‘aid-effectiveness’ intensified due to concerns that heavy em-
phasis on project-based and donor-driven funding was distorting
national planning and priority-setting. While some donors had sup-
ported new aid modalities like sector wide approaches and direct
budget support to low-income country governments in the 1990s,
major donors including USAID, rejected them, and as a result inter-
national initiatives for safe motherhood and child survival had con-
tinued to operate in parallel, with separate budgets and
management structures (Standing 2002). The proliferation of dis-
ease-specific PPPs reinforced vertical approaches and fitted poorly
with longer-term planning and financing of health sectors. This fed
into more general disquiet about the poor effectiveness of interna-
tional development assistance, giving rise to ‘ownership’, ‘align-
ment’, ‘harmonization’, ‘managing results’ and ‘mutual
accountability’ as core ideals that should underpin international aid
practices (Mosse and Lewis 2005). These principles, contained
within the Paris Declaration on Aid Effectiveness, were endorsed by
more than 100 signatories from donor and low-income country gov-
ernments, multilateral donor agencies, regional development banks
and international organizations (OECD DAC 2005). All the agen-
cies involved in the SMI supported the Paris Declaration, not least
because disease-specific donor-driven projects with separate budgets
often translated into neglect of cross-cutting health system issues
deemed necessary for reducing maternal mortality (Task Force on
Child Health and Maternal Health 2005). At the same time, it be-
came clear at policy and research events we attended around this
time that the Declaration also signalled that the SMI’s funding was
under threat, as donors became explicit about wanting to rationalize
and fund fewer global health initiatives.
Moving towards partnership
Together, these somewhat contradictory tendencies—greater com-
petition to survive as a single initiative combined with pressure to
harmonize and integrate development efforts—converged to create
an impetus for the SMI to find strategies to protect the status that
maternal health had achieved through being assigned as one of the
MDGs. Partnership formation was part of such a strategy.
A preamble to the establishment of the PMNCH was the cre-
ation of the Partnership for Maternal and Newborn Health in 2004.
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Already dismayed that MDG 4 on child survival was attracting
greater commitment than MDG 5 on maternal health, SMI leaders
we interviewed explained that they feared that the promotion of
newborn survival as a subsidiary goal of child survival would further
skew prioritization. They therefore pre-emptively proposed a merger
with the newly formed Healthy Newborn Partnership, successfully
persuading its leaders that a partnership would be mutually benefi-
cial, since newborn survival is so closely related with safe delivery
and women’s survival that any efforts to improve maternal health
would also benefit newborn survival.
With newborn survival as the link between MDGs 4 and 5, a
consensus soon emerged within the UN agencies and the broader ad-
vocacy communities that it would ‘make sense’ to incorporate the
existing child survival community into the new partnership.
Meanwhile, there were ongoing talks about forming a new Child
Survival Partnership to revive the Child Survival Revolution of the
1980s and drive progress on MDG 4. However, both maternal and
child health specialists we interviewed recalled that certain of those
donors who were particularly strongly committed to the Paris
Declaration, such as the UK Department for International
Development (DFID), made it clear that they would refuse to handle
requests from multiple partnerships working on what were arguably
inter-linked goals. According to a SMI member who later became
part of the PMNCH’s steering committee, donors ‘really wanted to
see this field co-ordinated and connected and they didn’t want sev-
eral sets of transaction costs for the funding that they ‘did’ want to
put into the work’. As another SMI leader recalled, ‘they said, “ei-
ther you merge or die, you are not funded,” so we decided to
merge’.
The PMNCH was officially established at the UN General
Assembly in 2005. Its vision, institutional structure and strategic ob-
jectives had been debated at the high-level meeting ‘Lives in the
Balance’ in New Delhi, India in April 2005, which we attended,
coinciding with the launch of the WHO’s World Health Report:
Make every mother and child count (WHO 2005). The Delhi
Declaration drafted at the meeting called on all countries to ‘orient
their national and sub-national development plans and budgets to
fully achieve the maternal and child health MDGs by 2015’
(PMNCH 2005).
The PMNCH was hosted by the WHO in Geneva. By the end of
2005, a Board and advisory committees had been assembled, draw-
ing representatives from across multiple constituencies: donors and
foundations, health care professionals, multi-lateral agencies,
NGOs, partner countries, researchers and academics, and the pri-
vate sector. The inclusion of donors and private-sector actors within
the governance structure was a major shift for the SMI, which had
excluded donors in a bid to secure its independence to work on con-
troversial issues like abortion. Like many PPPs, the PMNCH aimed
to promote knowledge and innovation to advance policy, service de-
livery and financing, do advocacy and consolidate resources and
promotion accountability. But it differed in its explicit endorsement
of the Paris Declaration on aid-effectiveness; the PMNCH promised
more appropriate financial and technical assistance to low-income
countries, including greater country ‘ownership’ of national policy
processes and global advocacy and policy advice aligned with na-
tional health and development plans (PMNCH 2009a). The
PMNCH intended to provide ‘catalytic’ financial and technical sup-
port to countries to implement a ‘continuum of care’ to accelerate
progress towards MDGs 4 and 5. The new partnership received
funding from the governments of Australia, Canada, Germany,
Italy, Netherlands, Norway, Sweden, UK and the USA, the World
Bank, UNICEF and the Gates and MacArthur Foundations, as well
as ‘in-kind’ support from many other partners (PMNCH 2015).
The promise of partnership
The PMNCH officially incorporated SMI actors and expertise and
thus brought an end to the SMI as it had existed, yet many safe
motherhood advocates accepted this development as inevitable and
even welcome. ‘It needs to happen’, explained a senior maternal
health specialist in an interview on the eve of the PMNCH’s launch,
‘because as a single topic we can’t fight this alone, we can’t survive’.
Many hoped that the PMNCH could help strengthen global priority
for maternal health through increased funding and stronger institu-
tional leadership; they hoped that Francisco Songane, the PMNCH’s
first director and an obstetrician and former Minister of Health
from Mozambique, would become the global maternal health cham-
pion the SMI had lacked. The PMNCH would also strengthen glo-
bal advocacy, several anticipated. The Partnership claimed that
‘more than 6 million maternal, newborn and child deaths would be
averted yearly if essential maternal, newborn and child health and
nutrition interventions are implemented at scale’ (PMNCH 2008).
This was, according to one American communication specialist, sim-
ply a ‘much better advocacy argument’ than the SMI’s call for action
to save 500 000 lives (the annual global maternal death estimate at
the time). As a UK-based maternal health epidemiologist put it, ‘It
makes sense to bung in the babies for the numbers game’ (Storeng
and Be´hague 2014).
Both maternal and child health specialists were optimistic that
the PMNCH would develop and generate support for a coherent set
of policy recommendations, overcoming what one editorial labelled
the ‘false and damaging dichotom[ies]’ between facility-based and
community-based approaches that had existed for maternal and
child health, respectively, since the 1980s (Lawn et al. 2006, p.
1474). As such, they were enthusiastic about the ‘continuum of care’
framework the PMNCH intended to help countries implement. The
continuum was an integrated ‘life cycle’ approach to health im-
provement linking, in time, care from pregnancy through birth, new-
born and young child health and, in place, the various levels of
home, community and health facilities (PMNCH 2009b). This
framework had important limitations; it focused heavily on clinical
interventions and ignored women’s health outside of pregnancy and
the social determinants of health (cf. Yamin and Boulanger 2014).
Yet, maternal health advocates welcomed its alignment of disease-
specific approaches and attention to cross-cutting issues like infra-
structure and human resources in the health sector, as well as its
support for EmOC and skilled birth attendance, issues they had long
struggled to generate support for through the SMI.
The challenges of institutional and policy integration
Despite the many clear strategic and ideological benefits of integra-
tion, the complexities of advancing multipronged initiatives quickly
came to the fore. For example, although the PMNCH aimed to be
inclusive, some members felt that they were not being well repre-
sented. One maternal health NGO representative complained that
the ‘elitist’ nature of the Inter-Agency Group—which had been
dominated by small and select group of UN agency senior ad-
visors—was being reproduced:
From what I understand, all the meetings that have been held so
far—the high-level meetings—are kind of elitist. Even though
they want to have these working groups, I don’t think that there’s
an attempt by the Partnership to open up the groups and invite
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people in from different organizations that were not part of this
elitist group before.
Two years into the PMNCH, a senior Belgian maternal health
epidemiologist similarly lamented, ‘I have not talked to anybody
that becomes shiny eyed when they talk about the global
Partnership. [No one seems to feel that this is] something new,
something big, something strong where we really get together’.
Coordination problems quickly tarnished the PMNCH’s exter-
nal credibility. At an evidence session for the UK House of
Commons International Development Committee inquiry into ma-
ternal health we attended in November 2007, committee members
expressed confusion about its remit, questioning why the WHO was
simultaneously host to the PMNCH and to two separate depart-
ments—Making Pregnancy Safer and Reproductive Health and
Research—working on women’s health. The committee’s report
concluded: ‘it is far from clear to us how the UN divides up responsi-
bility for different aspects of maternal, newborn and child health-
the overlapping remits between agencies has contributed to a lack of
confidence in the UN as a global leader’ (House of Commons
Select Committee on International Development, 2008, p. 25).
Meanwhile, a senior WHO health system specialist we interviewed
was critical of institutional wrangling in establishing the PMNCH:
‘strategy is [being] sacrificed for structural considerations, which re-
lates to “who’s going to host the secretariat” and junk like that,
which doesn’t really do a whole lot for mothers anywhere’.
Maternal health advocates, in turn, worried primarily about
their own weak position within the PMNCH. A senior UK-based
maternal health researcher, for instance, reflected: ‘When brought
together with the child health group, [we] have always been poor
relatives. . .always the less substantiated and less well supported
group. . .and the same is true in the Partnership’. Former SMI repre-
sentatives similarly alleged that despite the global rhetoric of ‘inte-
gration’, PMNCH donors continued to favour child health. ‘We are
the last of the trio to get money from Gates’, said a senior UNFPA
maternal health advisor, explaining that the Foundation had chan-
nelled $25 million through the PMNCH for child health pro-
grammes in Africa even though the Partnership had publicly
committed to aligned funding for maternal and child health.
Similarly, a ‘Global Business Plan’ devised by the Norwegian Prime
Minister and administered through the PMNCH had focused nar-
rowly on child survival until safe motherhood advocates eventually
persuaded the Board to include maternal health (see PMNCH
2009c).
Some informants attributed such apparent child health bias to
certain donors’ reticence to be associated with more politically sensi-
tive aspects of women’s health, especially abortion. The UNFPA ad-
visor cited above explained that his organization had already lost
USAID funding because of its work on abortion, and said he feared
that the Gates Foundation’s involvement in the PMNCH would ex-
acerbate the situation: ‘We haven’t received a single dollar [from the
US] since Bush. . . so, maternal health is linked to women’s health
and to abortion and some donors are sensitive [to this], even. . .
Gates. . .Melinda Gates is very religious, you know’. Others worried
that the newborn health lobby within the PMNCH was legitimating
such attitudes by, as one senior UK-based NGO advisor put it, ‘con-
sciously or unconsciously using some of the same language that anti-
abortionists use’. Although there has historically been deep ambiva-
lence within the SMI about whether or not to remain neutral in
pro-choice debates (Storeng and Be´hague 2013), a number of mater-
nal health advocates who were ideologically committed to repro-
ductive rights began to question the strategic value of the alliance
with the newborn health lobby. ‘I’m inclined to think that people
have gone for this new approach because newborns are something
that everyone coos over and it may be a way to kick-start new polit-
ical will and get more money into the field’, said the NGO advisor
cited above, ‘but I think there are risks that one ought to be aware
of’.
The maternal health coalition’s status as the ‘poor relative’
within the PMNCH was also seen as a reflection of continued lack
of commitment towards the integrated public health approaches
needed to address maternal mortality. A senior researcher claimed
that key PMNCH members pay lip service to maternal health, but
still hold ‘prejudice against the complexity of maternal health’ and
question the cost-effectiveness of key maternal health interventions
like skilled birth attendance:
You know, I’ve seen emails that probably shouldn’t come to me
that talk about the ‘elephant in the room’, which, you know, in
some ways summarizes some people’s perspectives of maternal
[health]. There is this attitude that ‘we don’t have the evidence
for maternal interventions but we just have to do it’. I’m not
going to name names, but there are several key members—
donors—within the Partnership who have, implicitly, if not expli-
citly, stated this.
Others implied that child and newborn health advocates within
the Partnership were complicit in creating this situation by distorting
the continuum of care concept to promote their own preference for
community-based care and selective ‘magic bullets’. For example, a
senior American maternal health epidemiologist accused newborn
health advocates of being insensitive to the potentially detrimental
policy impact of pushing for interim community-based solutions:
I think of myself as being pretty balanced on this issue. . .but I
find myself reacting to the newborn people. I have heard [one ad-
vocate], who is like Mr. Neonate, say, ‘you know, blah, blah,
blah, skilled attendance in countries like Bangladesh where there
aren’t enough providers and this, that and the other, there are
things that we could be doing right now in the home to save new-
borns’. This expression sets me off: ‘yes, we need skilled attend-
ance, but in the meantime . . .’ because what ‘in the meantime’
means to a policy-maker is ‘do nothing’.
Another senior maternal health epidemiologist similarly
described how her suggestion during a committee meeting to fore-
ground skilled birth attendance within the continuum of care frame-
work was immediately rejected: ‘I received quite negative feedback
from the neonatal and child people, saying that, ‘yes of course you
need a skilled attendant but it’s a long-term initiative. We need
short-term intermediate solutions’. This came up repeatedly. And
I’m uneasy with that claim’.
Self-protective responses and internal fragmentation
Several years into the new partnership, the on-going force of the ten-
sions that had divided the child and maternal health communities
since the 1980s put safe motherhood advocates in a bind. On the
one hand, they were committed—institutionally, financially and
conceptually—to the process of partnership-building that they had
initiated. On the other, many expressed disappointment that their
expectations had not been met, and some had started to fear that the
PMNCH could even be harmful to maternal health interests and
emphasized the importance of ‘protecting’ maternal health’s pos-
ition. ‘I would say that we have to fight, to constantly remind people
that the Partnership is for MDG 4 and 5’, said UNFPA’s senior ma-
ternal health advisor.
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A variety of self-protective practices emerged in response to such
perceptions. For example, some sought to challenge what they saw
as the distortion of the continuum of care concept. As a senior UK-
based maternal health researcher explained:
I think we need to make sure, all of us collectively, we need to
make sure that the M in MNCH does not get lost. We have to be
sure that, because maternal mortality is a longer-term interven-
tion and we have to look at issues of human resources and at
strengthening health infrastructure, that donors and governments
don’t just go for the quick-wins that are easier to do and have a
quick impact, but [rather that they] have a commitment to the
longer-term interventions.
Others, by contrast, responded more directly to the strategic de-
mands of generating funds and political attention by advancing a
series of maternal health-specific campaigns, even though this was
in tension with the PMNCH’s aim of an integrated policy approach.
A key example was the Women Deliver campaign spearheaded by
activists from within UNFPA and the NGO Family Care
International (which had served as the SMI’s secretariat). This cam-
paign culminated in a 3000-delegate conference in London in 2007
which we attended, calling for donor prioritization of maternal
health through the slogan ‘Invest in women—it pays’. While such
issue-specific advocacy is not necessarily contrary to the strategic
objectives of the PMNCH, it is telling that the conference stayed
clear of the ‘continuum of care’ rhetoric and instead promoted key
interventions to reduce maternal mortality, and framed investments
in maternal health as the fulcrum of achieving all the MDGs, includ-
ing child survival and poverty reduction. The conference organizers
adopted an instrumental, neoliberal economic logic that appealed to
donors, but that was in tension with the Partnership’s integration
rhetoric and jarred with the feminist, social justice discourse the
SMI had originally promoted.
Discussion: a global health success?
To what extent has the PMNCH advanced integration of policy
approaches at the global level? The Partnership has certainly cov-
ered considerably ground. As we have shown elsewhere, key players
in maternal and child health have spearheaded wide-ranging
research agendas that are resolutely committed to integration
(Be´hague and Storeng 2013), and they are doing this within the
parameters set by the Partnership (see, for example, Stenberg et al.
2014). Yet, our case study shows that the rhetoric of integration
often masks continued structural drivers (McCoy et al. 2013) that
bias the global health field towards vertical goals.
The ability to generate funding is often taken as evidence of the
success of global health PPPs (Shiffman et al. 2015). Indeed, in out-
lining its achievements, the PMNCH emphasizes that its annual
funded budgets rose from around US$6 million in 2009 to more
than US$10 million in 2015, and that it has leveraged additional re-
sources through global initiatives it has supported (PMNCH 2015).
For example, the Global Strategy for Women’s and Children’s
Health launched in 2010 is said to have generated an estimated
US$20 billion in new and additional money to women’s and chil-
dren’s health (PMNCH 2014). Independent analyses confirm that
funding to MNCH increased substantially in the first few years of
the new partnership, but this increase was proportional to increases
in funding for health in general and cannot necessarily be attributed
to the PMNCH’s efforts (Pitt et al. 2010). Moreover, there are ser-
ious concerns about sustainability (Hsu et al. 2012; Horton 2014).
Crucially, the extent to which global funding has translated into
integrated policy approaches at global or national levels is difficult
to establish. The increased funding to newborn health, for instance,
has focused on research, rather than large-scale implementation (Pitt
et al. 2012). While wider programmes targeting maternal and child
health, or even general primary health care programmes, mention
‘newborns’ more often in their descriptions, there is no evidence that
this has led to concrete integrated programing and joined-up think-
ing, or the health system strengthening that is needed to sustain inte-
gration (Pitt, personal communication 25.04.14). In fact, most
public health interventions remain targeted at women, newborns or
children, and few evaluations of interventions consider the impact
on more than one of these groups (McCoy et al. 2010).
The PMNCH strongly implies that health improvements can be
attributed to its efforts, saying that since it was formed in 2005, ‘glo-
bal attention and governments have turned to support and improve
the health of women’s and children’s health globally, and change
and improve [maternal and child mortality] statistics’ (PMNCH
2014). However, it is very difficult to attribute health improvement
to specific global-level initiatives; the attribution of ‘lives saved’ to
specific PPPs is not only prone to overestimation, but might also
negatively affect the overall governance of health systems and re-
inforce vertical programmes (McCoy et al. 2013).
At its core, a key challenge for institutional integration lies in the
notion of ‘partnership’ to which few ‘partners’ seem to subscribe
and many describe as ‘elitist’. It is problematic that PMNCH mem-
bers still primarily identify with one area of expertise, referring to
themselves and their colleagues as either maternal health, newborn
health or child survival ‘people’. The fact that political scientists
continue to analyse ‘issue attention’ to newborn and maternal sur-
vival separately rather than as part of broader political struggles
(e.g. Shiffman 2010; Tinker et al. 2010; Smith et al. 2014) also sug-
gests that disease-based approaches are not being challenged in any
significant way. Since the PMNCH was launched, the leading med-
ical journal The Lancet has even published separate series focused
on maternal, newborn and child health, without corresponding at-
tention to integrated policy approaches. Significantly, the
PMNCH’s policy discourse remains focused on technical aspects of
health improvement and an interpretation of integration focused on
the parallel scaling up of disease-specific interventions, eschewing
national governments’ role in public health or the social determin-
ants of health and gender issues that were so central in the SMI’s ini-
tial integrated policy agenda. After a decade of defining maternal
health primarily in terms of maternal mortality, the Partnership
claims that it now ‘belatedly’ focuses on reproductive health and has
even started to define its focus as ‘RMNCH’ to incorporate the ‘R’
of ‘reproductive health’ within the MNCH concept (Bustreo et al.
2012). Still, its public profiling makes little if any reference to its
position on and work within core reproductive health issues like un-
wanted pregnancy, unsafe abortion or gender-based violence and
discrimination, and it is not clear to what extent self-proclaimed re-
productive health advocates consider themselves to be part of the
Partnership.
Conclusion
Our case study contributes to the emerging ethnographic literature
on the rhetoric and reality of PPPs by showing the complexity of de-
veloping and maintaining partnership between actors with different
histories, social configurations and approaches to health improve-
ment. While key PMNCH actors claim there is now consensus about
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the value of partnership, we have shown that its history has also
been characterized by competitive tensions, which elicited protective
responses, not least from the safe motherhood contingent. The speed
and intensity of these responses were no doubt informed by the
SMI’s enduring struggle to assert itself, including its experience since
the 1980s of seeing maternal health subordinated to child health
(Storeng 2010). Ironically, however, such self-protective practices
may accentuate the kind of fragmentation to global health govern-
ance, financing and policy solutions that the Partnership was in-
tended to challenge.
Although the PMNCH has laudably embraced the aims of inte-
gration of policy approaches and institutional governance, global
health partnerships remain under pressure to appeal to donors by
being issue-specific and quick-results oriented (Buse and Harmer
2007). As our findings underscore, the cost of operating within an
extremely competitive global health arena may be at least a partial
renouncement of ambitions to broader social transformations in fa-
vour of narrower, but feasible and ‘sellable’ interventions (Irwin and
Scali 2007, p. 243). Until the PMNCH—and other PPPs—take a
more radical approach to the core structures of global health gov-
ernance within which they must operate, integration is likely to re-
main a difficult-to-implement ideal.
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